Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
€30 million Series D2 financing completed with participation from leading new and existing international investorsUp to €30 million financing facility secured from the European Investment Bank Paris,...
-
Financement de Série D2 de 30 millions d'euros avec la participation d'investisseurs internationaux de premier plan, nouveaux et historiquesMise en place d’une facilité de financement pouvant...
-
Paris, France, June 15, 2026 – TISSIUM, a medical technology company pioneering biomorphic programmable polymers for tissue reconstruction, today announced its selection to the French Tech...
-
Paris, France, le 15 juin 2026 – TISSIUM, société de medtech spécialisée dans le développement de polymères programmables biomorphiques pour la reconstruction des tissus, annonce aujourd'hui son...
-
Paris, France, Cambridge, USA, May 5th, 2026 – TISSIUM, a Medical Technology company pioneering biomorphic programmable polymers for tissue reconstruction, announced today it has appointed Marc...
-
Paris, France, Cambridge, USA, March 18, 2026 – TISSIUM, a Medical Technology company pioneering biomorphic programmable polymers for tissue reconstruction, is pleased to announce the publication of...
-
Paris, France, Cambridge, USA, November 28, 2025 – TISSIUM, a Medical Technology company pioneering biomorphic programmable polymers for tissue reconstruction, announced today the first commercial use...
-
Paris, France, Cambridge, USA, September 4 2025 - TISSIUM, a MedTech company pioneering biomorphic programmable polymers for tissue reconstruction, today announced further progress in its clinical...
-
Paris, France, Cambridge, USA, July 23, 2025 - TISSIUM, a MedTech company pioneering biomorphic programmable polymers for tissue reconstruction, today announced the commercial launch of...
-
This regulatory milestone marks TISSIUM’s entry into the U.S. market and establishes the foundation of the TISSIUM polymer platform for atraumatic tissue repair Paris, France, Cambridge, USA,...